Thomas Lehrnbecher | Medicine | Best Researcher Award

Published on 02/09/202502/09/2025 by Academic Excellence

Prof. Dr. Thomas Lehrnbecher | Medicine | Best Researcher Award

Prof. Dr. Thomas Lehrnbecher | Medicine | Goethe Universität Frankfurt | Germany

Dr. Thomas Lehrnbecher is a distinguished pediatric oncologist and hematologist, serving as Head of the Division of Pediatric Hematology and Oncology at Johann Wolfgang Goethe University, Frankfurt. With decades of experience, his clinical and research expertise lies in infections in immunocompromised pediatric patients, supportive care, and innovative therapeutic strategies for childhood cancers. His career spans leading roles in Germany and international collaborations at the National Cancer Institute, USA, where he trained as a post-doctoral fellow. A prolific researcher, he has published extensively in high-impact journals, shaping global practices in infection management and antifungal prophylaxis in children with cancer. Dr. Lehrnbecher has also contributed significantly to medical societies, committees, and working groups, reflecting his leadership in advancing pediatric oncology. Recognized with prestigious awards, he continues to drive progress in medicine through innovative research, clinical care, and mentorship, making him an influential figure in pediatric hematology and oncology worldwide.

Author profile

Orcid

Education

Dr. Lehrnbecher’s medical training reflects a strong foundation in pediatrics and subspecialization in oncology and infectious diseases. He earned his Board Exam in General Pediatrics in 1996, establishing his clinical foundation. His academic excellence and leadership were recognized in 2005, when he was awarded a Professorship at Johann Wolfgang Goethe University, Frankfurt, one of Germany’s leading medical institutions. That same year, he also earned a Diploma in Pediatric Infectious Diseases from the German Society for Pediatric Infectious Diseases, strengthening his expertise in managing complex infections. In 2007, he completed his Board Exam in Pediatric Hematology and Oncology, formally certifying his specialization in childhood cancers and blood disorders. Combined with his post-doctoral fellowship at the National Cancer Institute (NIH, USA), his education and training provided him with exceptional clinical and research competencies, which now serve as the foundation of his international reputation in pediatric oncology and infection medicine.

Experience

Dr. Lehrnbecher has cultivated an impressive career spanning over two decades in pediatric hematology and oncology. Since 2001, he has served as a Senior Consultant at Johann Wolfgang Goethe University, Frankfurt, providing expertise in pediatric cancer care and mentoring young clinicians. In 2018, he advanced to Head of the Division of Pediatric Hematology and Oncology, where he oversees patient care, clinical programs, and research initiatives. Earlier in his career, he worked as a Consultant at the Children’s Hospital, University of Würzburg (1999–2000), where he gained valuable clinical insights. A pivotal moment came during his post-doctoral fellowship at the National Cancer Institute, NIH, USA (1996–1999), under Dr. Stephen Chanock, where he developed a strong research focus on infections in immunocompromised children. His leadership in both clinical and research settings reflects his dedication to integrating science with practice, driving advancements in pediatric oncology, supportive care, and infection management worldwide.

Awards and Honors

Dr. Lehrnbecher’s contributions to pediatric oncology and infectious diseases have earned him numerous prestigious awards. In 2024, he received the Best Publication Award from the German Society of Mycology (DMykG), recognizing his impactful research. He previously won the Kind Philipp Award from the German Society of Pediatric Oncology and Hematology (GPOH) and the Poster Award from the International Society of Pediatric Oncology (SIOP). His groundbreaking work in mycology earned him the Outstanding Research in Mycology Award, while his contributions to histiocytic disorders were honored with the Nesbit Award from the Histiocyte Society. Earlier in his career, he was recognized with the Outstanding Research Award in Novel Therapeutic Strategies by the Children’s Cancer Foundation Mainz and the Educational Grant from the German Foundation of Cancer Aid. Collectively, these awards highlight his sustained excellence in clinical care, medical research, and innovation.

Research Focus

Dr. Lehrnbecher’s research is centered on improving the management of infections in immunocompromised pediatric patients, particularly those undergoing cancer treatment or hematopoietic stem cell transplantation. He has extensively studied antifungal prophylaxis, bacterial infections, and novel diagnostic markers for invasive fungal disease in children. His investigations aim to refine supportive care strategies, reduce infection-related mortality, and improve the quality of life for pediatric cancer patients. A particular focus of his research has been the efficacy of antifungal and antibiotic therapies, as well as the development of evidence-based guidelines for infection management. Beyond infectious diseases, his work also contributes to optimizing cancer treatment protocols, including long-term maintenance therapies for pediatric sarcomas. Through clinical trials, prospective studies, and international collaborations, Dr. Lehrnbecher has made significant advances in pediatric oncology. His contributions are widely recognized for bridging research and practice, helping set global standards for supportive care in children with cancer.

Publications

Assessing the Theoretical Efficacy of Combination Therapy Against Gram-Negative Infections in Neutropenic Pediatric Cancer Patients.
Mold-Active Antifungal Prophylaxis in Pediatric Patients with Cancer or Undergoing Hematopoietic Cell Transplantation.
Pediatric Patients with Stage IV Rhabdomyosarcoma Benefit from Long-Term Maintenance Therapy: CWS Trials Results.
Serum Beta-D-Glucan in the Diagnosis of Invasive Fungal Disease in Children: A Critical Analysis.
Cerebrospinal Fluid System Infection in Children with Cancer: A 14-Year Retrospective Analysis.
Infections during Non-Neutropenic Episodes in Pediatric Cancer Patients: A Prospective European Study.

Conclusion

Dr. Thomas Lehrnbecher is an internationally recognized leader in pediatric oncology and infectious diseases. His pioneering research, clinical leadership, and commitment to advancing supportive care in childhood cancer treatment have transformed patient outcomes worldwide. His achievements and continued impact make him a highly deserving candidate for the Medicine Award, symbolizing excellence in medical research and clinical innovation.

Wenkai Zhang | Materials Science | Best Researcher Award

Published on 02/09/202502/09/2025 by Academic Excellence

Mr. Wenkai Zhang | Materials Science | Best Researcher Award

Mr. Wenkai Zhang | Materials Science | Henan University | China

Dr. Wenkai Zhang is a distinguished scholar in polymer chemistry and materials science, currently serving as a Professor at the College of Chemistry and Chemical Sciences, Henan University (HENU), China. With a Ph.D. in Polymer Chemistry and Physics from Sun Yat-Sen University, he has developed an extensive research portfolio in advanced nanomaterials, carbon dots, and photonic systems. His international exposure as a Visiting Scholar at Mississippi State University broadened his research collaborations and scientific perspectives. Dr. Zhang has authored influential publications in top-tier journals, contributing to the advancement of nanostructured materials for applications in optical security, anti-counterfeiting, and functional composites. His excellence in teaching and research has been recognized with several prestigious awards, including the Faculty Teaching Award and Scientific and Technological Innovation Talent honor. As an active member of the Chinese Chemical Society and peer reviewer for leading journals, Dr. Zhang continues to inspire innovation and scientific discovery globally.

Author Profiles

Orcid | Google Scholar

Education

Dr. Wenkai Zhang began his academic journey with a Bachelor of Science in Chemistry from Qufu Normal University in 2008, where he gained a strong foundation in chemical principles and laboratory research. He pursued his doctoral studies at Sun Yat-Sen University, earning a Ph.D. in Polymer Chemistry and Physics in 2013. His Ph.D. research focused on advanced polymeric materials and their functional properties, laying the groundwork for his career in materials science. During this period, he engaged in extensive research on nanostructured polymers, photonic materials, and carbon-based functional composites. His doctoral work not only strengthened his technical expertise but also fostered a passion for interdisciplinary applications of chemistry in material innovation. Dr. Zhang’s international exposure further expanded during his time as a Visiting Scholar at Mississippi State University, where he collaborated with leading researchers, enhancing his academic vision and advancing his knowledge in nanomaterials and applied chemistry.

Experience

Dr. Wenkai Zhang has built a dynamic academic career characterized by teaching excellence, innovative research, and international collaborations. Since joining Henan University, he has held progressive academic appointments, including Associate Professor from 2017 to 2024 and subsequently Professor in the College of Chemistry and Chemical Sciences. His work spans across nanomaterials, polymers, and functional composites, with a particular focus on their applications in optical security, photonics, and anti-counterfeiting technologies. Between 2019 and 2020, he broadened his expertise as a Visiting Scholar at Mississippi State University, collaborating on cutting-edge material chemistry projects. Beyond his research, Dr. Zhang has excelled in teaching and mentorship, guiding students in developing research acumen and problem-solving skills. His recognition with multiple Faculty Teaching Awards underscores his dedication to education. Moreover, his active role as a peer reviewer for prestigious journals demonstrates his influence in shaping the global materials science community.

Awards and Honors

Dr. Wenkai Zhang’s career is marked by a series of notable awards and honors that reflect both his academic excellence and innovative contributions. In 2023, he was honored as a Scientific and Technological Innovation Talent in Kaifeng by the Kaifeng Municipal Government, acknowledging his groundbreaking research in nanomaterials and functional polymers. Earlier, in 2018, he was recognized as one of the Young Core Faculty Members in Henan Higher Education Institutions by the Henan Provincial Education Department, a testament to his leadership and academic promise. His exceptional teaching skills earned him the Faculty Teaching Award from Henan University in both 2015 and 2024, highlighting his commitment to nurturing the next generation of scientists. Beyond these distinctions, Dr. Zhang’s active membership in the Chinese Chemical Society and his extensive peer-review contributions to elite journals such as Advanced Materials and Nano Letters further underscore his impact on the field of materials science.

Research Focus

Dr. Wenkai Zhang’s research focuses on the design, synthesis, and application of advanced functional materials, particularly carbon-based nanomaterials, polymer composites, and photonic hydrogels. His work emphasizes the development of innovative approaches for optical security, anti-counterfeiting, data encryption, and environmentally sustainable material applications. Through his studies on carbon dots and electrospun nanofibers, he has pioneered strategies for fabricating materials with tunable optical and structural properties, enabling unique identifiers and physical unclonable functions. Dr. Zhang also explores supramolecular carbon dots and solvent-programmable hydrogels, advancing multifunctional platforms with applications in security technologies and sensors. His interdisciplinary approach bridges chemistry, materials science, and applied physics, contributing solutions to global challenges in authentication, sustainability, and information protection. By combining theoretical insights with experimental innovation, Dr. Zhang’s research not only deepens scientific understanding but also translates into impactful applications that benefit academia, industry, and society at large.

Publications

Template-Guided Assembly of Organosilica Nanodots for Optical Security.
Conformal Plasmonic Gratings on Nanofiber Membranes for Holographic Security.
Patternable Siloxane-Carbon Dots for Luminescent Microstructures.
Solvent-Programmable Photonic Hydrogels with Tunable Properties.
Ethanothermal Synthesis of Dual Emissive Carbon Dots.
Flame Retardancy in Polyamide Composites via DOPO-Functionalized Copolymers.
Cryptosystem Development Using 2D-SDMCHM and Hexagon Prediction.
Multicolor Carbon Dot Nanofibers for Anti-Counterfeiting.
Feature Encoding of Electrospun Nanofibers for Authentication.
Dual Fluorescence in Carbon Dots from Quinone Derivatives.
Environment-Sensitive Carbon Dots for Anti-Counterfeiting.
Assembly of Plasmonic Nanocavities for Ultrafast Emission.
Electrospun Nanofibers as Unique Identifiers for Security.
ESIPT Fluorophores in Carbon Dots for Multi-Anti-Counterfeiting.
Insights into Dual-Emissive Carbon Dots via Solvothermal Synthesis.
Photoinduced Iron-Catalyzed ipso-Nitration of Aryl Halides.
Emission Enhancement in Polyfluorene Copolymers via Plasmonics.
Quantification of Optical Properties in Perovskite Nanocrystals.
Purcell-Enhanced Emission from Perovskite Quantum Dots.

Conclusion

Dr. Wenkai Zhang exemplifies excellence in materials science through his innovative research, impactful teaching, and international collaborations. His pioneering work on nanomaterials, polymers, and photonic systems addresses critical global challenges in authentication, sustainability, and advanced technologies. With numerous awards, distinguished publications, and an active role in the scientific community, he stands as a leading figure shaping the future of materials science. His contributions make him a strong candidate for recognition through prestigious awards, inspiring continued advancement in both academia and industry.

Akriti Chugh | Business | Best Researcher Award

Published on 29/08/202529/08/2025 by Academic Excellence

Dr. Akriti Chugh | Business | Best Researcher Award

Dr. Akriti Chugh | Business | Institute of Innovation in Technology and Management | India

Dr. Akriti Chugh is a dedicated academic professional with over seven years of experience as a management faculty at prestigious institutions in India. With expertise in international business, managerial economics, marketing, and business analytics, she has contributed extensively to both teaching and research. She has served in various academic roles across renowned universities, including Bharati Vidyapeeth, Guru Nanak Institute of Management, Rukmini Devi Institute of Advanced Studies, and Delhi University. Beyond academics, she has corporate experience as an HR Executive and Business Development Executive, which enriches her ability to bridge theory with real-world practice. Her doctoral research at Jamia Hamdard University explored the interplay of dual narcissism, psychological empowerment, and ownership in shaping entrepreneurial intentions. An active contributor to international conferences, Dr. Chugh has presented and published impactful research in Scopus-indexed journals. Her career reflects a strong commitment to education, mentorship, and advancing knowledge in the field of business management.

Author Profile

Google Scholar

Education

Dr. Akriti Chugh holds a Ph.D. in Entrepreneurial Studies from Jamia Hamdard University, Delhi (2024). Her doctoral thesis, “Examining the Role of Dual Narcissism, Psychological Empowerment, and Ownership in Shaping Entrepreneurial Intentions: A Mixed Method Approach”, highlights her expertise in entrepreneurship and psychology-driven management research. Prior to her Ph.D., she completed a Master of Business Administration (MBA) in International Business from Bharati Vidyapeeth School of Distance Education in 2015, which equipped her with strong foundations in global business strategies and cross-border trade practices. She began her academic journey with a Bachelor of Technology (B.Tech.) in Electronics and Communication from St. Margaret Engineering College, Rajasthan (2012), gaining analytical, problem-solving, and technical skills. Dr. Chugh has further enhanced her knowledge through specialized certifications, including UGC-NET qualification, Google Analytics, Data Science (R Basics from HarvardX), and Faculty Development Programs (FDPs) on Managerial Economics and International Business. Her interdisciplinary academic journey reflects her holistic approach to business education.

Experience

Dr. Akriti Chugh has over seven years of rich academic and corporate experience. She currently serves as a Guest Lecturer at Jesus and Mary College, University of Delhi, where she teaches Business Analytics, Finance for Everyone, and Sustainable Business Planning. Previously, she held positions as Assistant Professor at Rukmini Devi Institute of Advanced Studies, where she mentored MBA dissertation projects and contributed to student development. She has also been associated with Guru Nanak Institute of Management & IT, Bharati Vidyapeeth University, and Softdot Hi-Tech Education Institute, teaching subjects such as International Business, Project Management, Microeconomics, and Marketing Management. Beyond academia, she worked as an HR Executive at Incyber Media and Technologies, and as a Business Development Executive at Nityo Infotech Services, gaining industry-level insights. She has actively contributed to event organization, cultural initiatives, and mentorship programs. Her dual expertise in corporate and academic environments strengthens her ability to deliver practical and research-driven education.

Awards and Honors

Dr. Akriti Chugh has earned recognition for her scholarly contributions and teaching excellence. She was awarded the Best Paper Award at the Responsible & Resilient Business Research Conference (BIMTECH, 2022) for her research on the relationship between personality traits and entrepreneurial orientation. She has presented impactful papers at international and national conferences, including those organized by IIM Nagpur, Jamia Hamdard, Bhupal Nobels University, and Jagan Institute of Management Studies. Her conference presentations have covered diverse areas such as sustainable cities (SDG 11), neuroticism and entrepreneurial orientation, digital learning outcomes, and NGO management. She has also participated in prestigious case colloquiums, including one at Aligarh Muslim University. Recognized for her research-driven teaching, she has been invited as a guest lecturer at leading academic institutions. Her contributions demonstrate a strong balance of academic rigor, innovation, and applied research, reflecting her position as a forward-looking scholar committed to advancing management education.

Research Focus

Dr. Akriti Chugh’s research is centered on the intersections of entrepreneurship, psychology, international business, and sustainable management practices. Her doctoral research examines the role of dual narcissism, psychological empowerment, and ownership in shaping entrepreneurial intentions, providing fresh insights into the behavioral drivers of entrepreneurship. She has published in Scopus-indexed journals, including studies on entrepreneurial intention and educational resilience in challenging times. Her conference papers have addressed topics such as digital learning, sustainable urban development, and entrepreneurial orientation, showcasing her interdisciplinary approach. She also explores the integration of technology, data analytics, and business sustainability, aligning her research with contemporary global trends. Additionally, her work with NGOs reflects her interest in social entrepreneurship and community development. Dr. Chugh’s research blends academic depth with real-world application, contributing to both scholarly literature and practical strategies for business growth, educational innovation, and sustainable development in emerging economies.

Publications

Investigating the Influence of Dual Narcissism on Entrepreneurial Intention with Psychological Empowerment – Journal of Enterprising Communities.
The Paradox of Keeping Education Afloat During Troubled Times: A Case of Kilkaari-Bachpan Ki – Emerald Emerging Markets Case Studies.

Conclusion

Dr. Akriti Chugh stands as an accomplished academic and researcher whose expertise spans teaching, research, and corporate practice. With a strong foundation in international business, entrepreneurship, and managerial economics, she has contributed meaningfully to higher education and scholarly literature. Her publications, awards, and research-driven teaching establish her as a future-oriented scholar dedicated to advancing business education and practice.

Inamul Hasan Madar | Medicine | Outstanding Scientist Award

Published on 28/08/202528/08/2025 by Academic Excellence

Prof. Dr. Inamul Hasan Madar | Medicine | Outstanding Scientist Award

Prof. Dr. Inamul Hasan Madar | Medicine | Yenepoya Universtiy |India

Dr. Inamul Hasan Madar is a distinguished researcher and educator in the field of biochemistry with a specialization in oncology proteogenomics. He earned his PhD from Korea University, a globally ranked institution, and has since developed extensive expertise in cancer genomics, multiomics integration, and bioinformatics. With a strong commitment to advancing medical research, Dr. Madar has served as an adjunct faculty at Saveetha Medical College (SIMATS), where he has mentored PhD, MD, MBBS, and MSc students in cutting-edge biomedical sciences. His international research experience includes appointments at Korea University and Hanyang University in South Korea, where he contributed to high-impact oncology projects. As Director and Lead of Canary Oncoceutics India, he has bridged the gap between research and industry by leading innovative onco-therapeutic initiatives. Widely published in top-tier journals, Dr. Madar has also served as a reviewer for international journals and as a member of prestigious scientific societies worldwide.

Author profile

Orcid

Education

Dr. Madar’s academic journey reflects a deep pursuit of excellence in biomedical sciences. He earned his PhD in Biochemistry, specializing in Onco-Proteogenomics, from Korea University, Seoul, ranked among the top global universities. His doctoral work focused on proteogenomic profiling and cancer biomarker discovery, positioning him at the forefront of precision oncology. Before this, he pursued advanced training in bioinformatics, molecular biology, and proteomics, equipping him with multidisciplinary skills to tackle complex biomedical challenges. His postgraduate education emphasized molecular diagnostics and computational approaches, while his undergraduate studies laid the foundation in biochemistry and clinical applications. Dr. Madar has also completed specialized training programs in next-generation sequencing (NGS), computational modeling, molecular docking, and drug discovery pipelines. Furthermore, he has been actively engaged in faculty development programs, including pedagogy training for undergraduate teaching in life sciences and biotechnology. This comprehensive educational background underscores his ability to combine research innovation with academic excellence.

Experience

Dr. Madar’s professional experience spans academia, research, and industry. He currently serves as Adjunct Faculty at Saveetha Medical College, SIMATS, where he mentors MBBS, MD, MSc, MPhil, and PhD students in research methodologies, cancer biology, and bioinformatics. He is also Director and Lead (Marketing) at Canary Oncoceutics India, overseeing translational oncology research and innovation in oncoceutical product development. Internationally, he worked as a Visiting Scientist at Korea University, specializing in proteogenomics, and as a Researcher at Hanyang University, Seoul, in bioengineering. In India, his previous roles include Scientist & Course Coordinator at Biocuration, where he designed genomics and drug development modules, and Junior Scientist at iPro Technologies. He has also contributed as a guest lecturer at Bharathidasan University, training future biochemists. His expertise extends to designing computational pipelines, analyzing multiomics datasets, and leading cross-disciplinary projects that bridge laboratory science and clinical application, particularly in cancer therapeutics and biomarker discovery.

Awards and Honors

Dr. Inamul Hasan Madar has received widespread recognition for his contributions to biomedical research and education. His publications in high-impact journals such as Nature Cancer, Oncotarget, Briefings in Bioinformatics, and Molecular Cancer have positioned him among leading voices in proteogenomics and cancer research. He has served as a peer reviewer for several prestigious journals, including Nature’s Scientific Reports, Frontiers in Oncology, BMC Medical Genomics, and Journal of Translational Medicine. He has been actively involved in international professional societies, including the American Association of Cancer Research (AACR), American Society for Biochemistry and Molecular Biology (ASBMB), International Society of Computational Biology (ISCB), and South African and Korean Mass Spectrometry Societies. His leadership roles include serving as Vice President of ISCB-RSG India, demonstrating his dedication to strengthening scientific networks. He has also mentored numerous graduate and medical students, guiding them to publish impactful research, file patents, and develop translational medical applications.

Research Focus

Dr. Madar’s research focus lies at the intersection of cancer genomics, proteogenomics, and computational biology. He specializes in integrating multiomics datasets to identify novel biomarkers and therapeutic targets for treatment-resistant cancers, particularly cervical, prostate, and oral squamous cell carcinoma. His expertise in next-generation sequencing (RNA-Seq, Exome-Seq) and bioinformatics has enabled him to develop innovative pipelines for cancer biomarker discovery, molecular subtyping, and clinical variant interpretation. Beyond oncology, he has contributed to research in neurobiology, metabolic disorders, cardiovascular protection, and bioactive peptides against diabetes and obesity. His translational approach emphasizes the “bench-to-bedside” concept, applying computational models and molecular profiling to guide precision medicine strategies. Dr. Madar has also explored theranostic targets, signaling networks, and novel oncoceutical formulations. His interdisciplinary collaborations with international research groups have advanced drug design, CAR-T therapy applications, and personalized treatment strategies, positioning him as a pioneer in cancer research and translational medicine.

Publications

Correction to: Proteogenomic characterization of molecular and cellular targets for treatment-resistant cervical cancers.
Molecular analysis of HPV16 and HPV18 oncogenes in oral squamous cell carcinoma.
Proteogenomic characterization of treatment-resistant subtypes in cervical cancers.
Theranostic Target NSUN2 uncovered with systematic assembly of 805 datasets.
Unravelling the phosphoregulatory network of PKC-delta (PKC-δ).
BDNF-TrkB signalling: A neurotrophic pathway to cardiovascular protection.
Physiological activities of bioactive peptides against diabetes and obesity.
SGLT2 inhibitors as dual therapeutic targets for cardiovascular and renal health.
Biobased nanomaterials and rhizobacteria for sustainable plant growth.
CAR-T therapy in oral squamous cell carcinoma: Current innovations and future prospects.

Conclusion

Dr. Inamul Hasan Madar exemplifies excellence in translational medicine, combining cutting-edge cancer research with dedicated academic mentorship. His impactful publications, international collaborations, and leadership in oncology research position him as a transformative figure in biomedical sciences. Through his expertise in proteogenomics and bioinformatics, he continues to advance precision medicine while inspiring the next generation of medical researchers.

Dr.J.Brintha Jei | Dentistry | Best Researcher Award

Published on 28/08/202528/08/2025 by Academic Excellence

Dr. J. Brintha Jei | Dentistry | Best Researcher Award

Dr. J. Brintha Jei | Dentistry | SRM Dental College | India

Dr. J. Brintha Jei is a distinguished dental professional and academician with expertise in Prosthodontics and Periodontics. She began her journey in dentistry by earning her BDS degree with distinction from Rajas Dental College under The Tamil Nadu Dr. M.G.R. Medical University in 2005. Pursuing her passion further, she completed her MDS in Prosthodontics from Vinayaka Missions Shankaracharya Dental College in 2009. With over 15 years of academic and clinical excellence, Dr. Brintha is currently serving as Associate Professor in the Department of Prosthodontics at SRM Dental College, Ramapuram. Her career is marked by outstanding contributions to teaching, patient care, research, and innovation. She has authored more than 50 research papers in reputed international and national journals, written textbook chapters, and holds two patents. Dedicated to professional service, she is actively involved in dental societies, peer reviewing, and conference organization, while also pursuing her Ph.D. in Dentistry.

Author Profiles

Orcid | Google Scholar

Education

Dr. J. Brintha Jei has pursued her academic journey with consistent dedication and academic brilliance. She completed her undergraduate studies at Rajas Dental College, affiliated with The Tamil Nadu Dr. M.G.R. Medical University, in 2005, graduating with distinction and securing top honors in Periodontics. Recognizing her aptitude for advanced learning, she pursued her postgraduate education in Prosthodontics at Vinayaka Missions Shankaracharya Dental College, completing her MDS in 2009. Her education has been strongly rooted in both theoretical knowledge and practical training, laying a solid foundation for her career as a clinician, researcher, and academician. Currently, she is advancing her scholarly pursuits through a Ph.D. program in Dentistry, reflecting her commitment to lifelong learning and research. Her educational journey showcases a blend of academic excellence, specialization in clinical dentistry, and innovation, positioning her as a role model in the dental field.

Experience

With more than 15 years of professional expertise, Dr. J. Brintha Jei has made significant contributions to dentistry through teaching, clinical practice, and research. She is presently an Associate Professor in the Department of Prosthodontics at SRM Dental College, Ramapuram, where she mentors undergraduate and postgraduate students. Her teaching extends beyond the classroom, with hands-on workshops, pre-conference courses, and clinical demonstrations that provide students with practical insights into modern prosthodontic practice. Clinically, she is renowned for her precision and patient-centered approach in restorative and prosthodontic treatments. Alongside academics, she has published extensively in reputed international journals, authored textbook chapters, and holds patents that highlight her innovative mindset. She has delivered guest lectures at national and state conferences and has actively organized scientific programs, including international, national, and state-level conferences. Her multifaceted experience reflects her leadership in advancing dental education, clinical care, and interdisciplinary collaboration.

Awards and Honors

Dr. Brintha’s career is decorated with academic achievements, professional recognition, and research contributions. She graduated with distinction during her undergraduate studies, securing top honors in Periodontics, which highlighted her academic brilliance early on. Over the years, she has received recognition for her scholarly publications, with her research being featured in PubMed, Scopus, and Web of Science-indexed journals. Her contributions to innovation in dentistry are evident through two patents, underscoring her commitment to advancing clinical solutions. As an active member of professional bodies, she has earned key leadership roles, such as Executive Committee Member of the Indian Prosthodontic Society – Tamil Nadu & Pondicherry Branch and Joint Secretary of the Indian Society of Prosthodontics – Restorative – Periodontics (ISPRP). In addition, her role as a peer reviewer for reputed journals further demonstrates the respect she commands in the academic community. Her honors reflect her commitment to excellence in dentistry.

Research Focus

Dr. J. Brintha Jei’s research focus lies at the intersection of clinical excellence, innovation, and interdisciplinary collaboration in dentistry. Her primary research interests include prosthodontics, restorative dentistry, and periodontics, with an emphasis on improving patient care through advanced treatment methodologies. She is passionate about material science, digital dentistry, and innovative prosthodontic techniques that enhance oral rehabilitation outcomes. Her contributions extend to exploring implant dentistry, minimally invasive approaches, and aesthetic restorative practices. With more than 50 publications indexed in international databases, her work has contributed to the global pool of dental research, offering valuable insights for clinicians and academicians alike. Beyond publishing, she has written textbook chapters and filed patents, translating her research into practical applications. Currently pursuing her Ph.D., Dr. Brintha continues to expand her research scope, fostering innovation that bridges clinical needs with cutting-edge technology to improve dental care outcomes worldwide.

Publications

Comparative analysis of prosthetic materials in restorative dentistry.
Evaluation of implant-supported prostheses for edentulous patients.
Advances in digital workflows for prosthodontic rehabilitation.
Biocompatibility of dental materials in clinical applications.
Clinical outcomes of full-mouth rehabilitation in compromised patients.
Textbook contributions on prosthodontics and restorative dentistry.
Molecular insights into periodontal health and restorative practices.
Innovation in maxillofacial prostheses for rehabilitation.
Trends in prosthodontics: A global research perspective.
Systematic reviews in restorative and prosthetic dental care.

Conclusion

Dr. J. Brintha Jei exemplifies excellence in dentistry through her achievements as a clinician, academician, and researcher. Her career reflects a balance of patient care, teaching, and groundbreaking research, making her a valuable contributor to the advancement of prosthodontics and dentistry as a whole. With her ongoing Ph.D. and her leadership roles in professional societies, she continues to inspire future dental professionals. Her scholarly output, innovation, and dedication to interdisciplinary collaboration strengthen her candidacy for recognition in academic and clinical dentistry.

Sasikumar Kuppusamy | Chemistry | Best Researcher Award

Published on 26/08/202526/08/2025 by Academic Excellence

Mr. Sasikumar Kuppusamy | Chemistry | Best Researcher Award

Mr. Sasikumar Kuppusamy | Chemistry | Sacred Heart College Autonomous | India

Dr. Kuppusamy Sasikumar, Ph.D., is a dedicated researcher in the Department of Chemistry at Sacred Heart College (Autonomous), affiliated with Thiruvalluvar University, Tamil Nadu, India. With a strong academic foundation and extensive research expertise, he specializes in renewable energy, nanostructured materials, dye-sensitized solar cells, photocatalytic hydrogen production, and environmental chemistry. His doctoral work, “Tailoring Nanostructured Materials for Enhanced Performance in Renewable Energy Applications,” focuses on advanced material design for energy conversion and storage. He has collaborated with premier research institutes such as IIT Palakkad, NCL Pune, and Madurai Kamaraj University, gaining exposure to cutting-edge scientific techniques. Dr. Sasikumar has published impactful research in international journals and presented at prestigious conferences, earning recognition for his innovative approaches. A mentor to budding scholars, he has supervised multiple postgraduate and MPhil students. His vision is to harness chemistry-driven innovation to address global energy and environmental challenges, contributing to sustainable scientific progress.

Author Profiles

Orcid | Google Scholar

Education

Dr. Kuppusamy Sasikumar’s educational journey reflects his deep commitment to chemistry and interdisciplinary research. He began with a B.Sc. in Chemistry from Thiruvalluvar University, followed by an M.Sc. in Chemistry from Periyar University, Salem, India, where he developed strong foundations in analytical and materials chemistry. He advanced to an M.Phil. in Chemistry at Thiruvalluvar University, focusing on applied nanostructured materials. His doctoral studies at Sacred Heart College, under Thiruvalluvar University, further elevated his expertise. His Ph.D. thesis, “Tailoring Nanostructured Materials for Enhanced Performance in Renewable Energy Applications,” explores vanadium-doped ZnO and silver-based nanocomposites for solar cells, supercapacitors, and photocatalysis. He also underwent advanced training in thin-film and DSSC fabrication at the National Chemical Laboratory (NCL), Pune with Prof. C.S. Gopinath, broadening his technical proficiency. This educational progression has equipped him with both theoretical knowledge and experimental skills, shaping him into a capable scientist in sustainable energy and material science.

Experience

Dr. Sasikumar has gained rich experience in advanced material synthesis, energy applications, and academic mentorship. During his Ph.D. research at Sacred Heart College (2019–2025), he specialized in synthesizing and characterizing nanostructured materials, including vanadium-doped ZnO and silver-based composites for solar and photocatalytic applications. His hands-on expertise spans solution combustion, sol-gel, hydrothermal methods, and thin-film fabrication techniques such as spray coating, spin coating, and doctor blade methods. He has worked on several funded research projects, including UGC Minor Research Project, Don Bosco Research Grant, and Fr. Carreno Research Grant, contributing significantly to energy material innovations. As a mentor, he guided postgraduate and MPhil students in renewable energy-focused projects, fostering research leadership. He has presented findings at national and international conferences, winning recognition such as Best Poster Award at ICCSN 2019 (VIT, Vellore). His collaborations with IIT Palakkad, NCL Pune, and other reputed institutions highlight his engagement with interdisciplinary and applied scientific research.

Awards and Honors

Throughout his academic and research career, Dr. Kuppusamy Sasikumar has received recognition for his outstanding contributions in chemistry and renewable energy research. He has been awarded multiple institutional research grants, including the UGC Minor Research Project, Don Bosco Research Grants, and the Fr. Carreno Research Grant, reflecting trust in his innovative scientific pursuits. His research presentations have been acknowledged at international platforms, notably with the Best Poster Award at the International Conference on Chemical Sciences and Nanomaterials (ICCSN-2019) at VIT, Vellore. His participation in prestigious conferences, including ICETC 2020, IC-RAAM 2019, and SMART 2020, demonstrates his active engagement in global scientific discussions. In addition, his collaborative projects with premier institutes such as IIT Palakkad and NCL Pune underline his contribution to interdisciplinary research. These honors highlight his potential as a rising researcher in chemistry, committed to impactful scientific solutions addressing energy and environmental challenges.

Research Focus

Dr. Sasikumar’s research is centered on renewable energy materials, nanotechnology, and environmental chemistry. His work explores the synthesis and application of nanostructured materials for dye-sensitized solar cells (DSSC), supercapacitors, and photocatalytic hydrogen production. He focuses on tailoring the structural, electronic, and optical properties of advanced materials such as vanadium-doped ZnO, silver-based composites, and perovskite oxides, enhancing their efficiency for energy conversion and storage. He has developed expertise in thin-film fabrication for photo- and electrocatalytic applications, contributing to sustainable clean energy technologies. His research further extends to photo(electro) catalysis and environmental remediation, with innovations in hazardous dye degradation and water splitting for green hydrogen generation. His collaborations with IIT Palakkad, NCL Pune, and other reputed institutes have strengthened his interdisciplinary approach. Dr. Sasikumar’s long-term vision is to advance affordable, scalable, and environmentally friendly energy solutions through material science, bridging the gap between laboratory innovation and societal applications.

Publications

Fuel Influenced Nanorod to Nanosphere Transformation of Vanadium doped ZnO for Dye-Sensitized Solar Cells.
Natural Carbon Template on Ag-ZnO Nanocomposites for Supercapacitor, Hydrogen Production & Antifungal Activity.
Structure Directing Amine Mediated Synthesis of Mn Doped ZnO Microrods for Dye Degradation.
Tuning Structural & Magnetic Properties of SrSnO3 Nanorods for Enhanced DSSC Performance.
Influence of Blocking Layer on Hf and V Doped Perovskite SrSnO3 for DSSCs.
3D CoMoO4 Nanoflake Arrays for Enzyme-less Electrochemical Glucose Sensors.
Scalable Thin-Film TiO2 Membranes for Hydrogen Production via Water Splitting (Under Construction).

Conclusion

Dr. Kuppusamy Sasikumar is an emerging researcher whose work in chemistry bridges renewable energy, nanomaterials, and environmental sustainability. His academic background, practical expertise, and impactful publications highlight his ability to contribute to global energy solutions. With a commitment to mentoring and interdisciplinary collaboration, he represents the next generation of scientists driving sustainable innovation.

Syed Aasim Syed Nasir | Medicine | Excellence in Research

Published on 26/08/202526/08/2025 by Academic Excellence

Mr. Syed Aasim Syed Nasir | Medicine | Excellence in Research

Mr. Syed Aasim Syed Nasir | Medicine | Tbilisi State Medical University | Georgia

Syed Aasim Syed Nasir is a dedicated fourth-year medical student at Tbilisi State Medical University, Georgia, committed to advancing medical research and clinical practice. His academic journey is complemented by extensive research contributions in cardiology, oncology, infectious diseases, and orthopedic surgery. With a growing publication record in reputed journals and conferences, he demonstrates strong skills in investigation, methodology, and medical writing. He has actively presented case reports, systematic reviews, and clinical studies at international platforms, earning recognition for his innovative insights. Beyond research, Syed Aasim is involved in leadership roles within medical organizations, fostering academic collaboration among peers worldwide. His internships and observerships in Dubai and Nigeria further enriched his exposure to diverse healthcare systems. Fluent in multiple languages and active in global medical societies, he exemplifies a well-rounded future physician-researcher with aspirations to bridge clinical medicine, academic excellence, and impactful scientific contributions to global health.

Author Profile

Orcid

Education

Syed Aasim Syed Nasir began his educational journey at Our Own English High School, Sharjah, UAE (2007–2019), where he developed a strong academic foundation. He then pursued his higher education at Velammal Vidhyashram School, Chennai, excelling in the sciences and preparing for a career in medicine. In 2021, he enrolled at Tbilisi State Medical University – School of Medicine, Georgia, where he is currently a Doctor of Medicine candidate. His education extends beyond formal coursework, as he participates in research training, medical writing, and scientific presentations at both national and international levels. His certifications in PALS, First Aid, CPR, ACLS, and BLS (in progress) add clinical preparedness to his academic excellence. Actively engaged in self-directed learning, he complements his curriculum with research in cardiology, oncology, and obstetrics, bridging classroom knowledge with real-world medical applications, shaping him into a future physician-scientist of global relevance.

Experience

Syed Aasim’s experience spans clinical exposure, research collaborations, leadership, and volunteerism. He completed observerships at Zulekha Hospital, Dubai, gaining insights into multidisciplinary patient care, and undertook a Psychnovation Neuroscience Internship, Nigeria, enhancing his research and clinical interpretation skills. He has served as a part-time researcher with the International Journal of Clinical Research (IJCR) and contributed to cardiology projects within IJCR Research Working Group. His leadership roles include General Secretary of ClinNova International, PR Team Member of IJCR Conference, Judiciary Council Member at GIMSOC, and University Head Representative. He also actively participated in Project IMG (USA) as a Unity Agent, furthering international student collaboration. His experiences combine academic rigor with hands-on exposure to clinical medicine, surgical case analysis, systematic reviews, and patient-centered research. These engagements reflect his commitment to developing as a medical leader, researcher, and clinician with both local and international impact.

Awards and Honors

Though early in his career, Syed Aasim has already earned recognition in multiple academic and professional avenues. His posters and case reports have been accepted and presented at high-impact platforms such as the Royal Society of London (2025) and the European Hip Society Congress, Thessaloniki, Greece (2025). His research on oncology, orthopedics, cardiology, and obstetrics has been acknowledged in international medical conferences, highlighting his ability to address complex diagnostic and therapeutic challenges. His selection as Georgia Ambassador for IJCR (2024–2025) underscores his leadership in research dissemination. Additionally, his active participation in medical student societies such as GIMSOC, SSSG, IASSS, and ClinNova International showcases his growing influence in academic medicine. These honors reflect both academic excellence and his proactive approach to advancing collaborative medical research. His consistent recognition in prestigious forums demonstrates his trajectory toward becoming a globally respected physician-researcher in medicine.

Research Focus

Syed Aasim’s research focuses on advancing clinical medicine through a multidisciplinary approach. His work spans oncology, cardiology, orthopedics, neurology, infectious diseases, and obstetrics/gynecology, reflecting his commitment to solving pressing healthcare challenges. He has investigated glioblastoma surgical outcomes, pharmacological mechanisms of UV-induced skin mutations, rheumatological impacts on cardiovascular health, and surgical complexities in gynecological disorders. His systematic reviews and meta-analyses address critical gaps in evidence-based medicine, such as hip arthroplasty, meniscal tear management, and cardiotoxicity biomarkers in cancer patients. He also explores therapeutics in infectious disease management, contributing reviews on measles outbreaks and innovative treatment strategies. His interest in women’s health and perinatal care is reflected in ongoing studies on melatonin supplementation in pregnancy and heart failure outcomes in women versus men. With a balance between clinical case reports, systematic reviews, and mechanistic research, his focus lies in generating translational insights that directly impact patient care and public health.

Publications

A Diagnostic Chameleon: Genital Tuberculosis Mimicking Ovarian Malignancy – Case Report.
Uterine Didelphys with OHVIRA Syndrome: Diagnostic and Surgical Challenges.
Navigating the Pharmacological Landscape of UV-Induced Mutations in Skin Carcinogenesis.
Comprehensive Review of Measles: Outbreak Trends, Clinical Manifestations, and Therapies.
Glioblastoma Surgery: Comparative Study of Resection Degree and Survival Results.
Rheumatoid Arthritis and Cardiovascular Mortality Trends in Postmenopausal Women.
Glioblastoma Multiforme Surgery: Comparative Survival Investigation – IJCR 2024.
Arthroscopic Partial Meniscectomy vs Exercise Therapy for Meniscal Tear: Systematic Review.
Short Stem vs Standard Stem Total Hip Arthroplasty: A Systematic Review.
Melatonin Supplementation in Pregnant Women: Neonatal Brain Maturation Study (In Progress).
Impact of SGLT2 Inhibitors on HFpEF Outcomes: Gender-Based Analysis (In Progress).
Rapid-Onset Obesity with Hypothalamic Dysfunction: Comprehensive Review (In Review).
Infective Endocarditis Post-TAVR vs SAVR: A Comparative Study (In Review).
NT-ProBNP/BNP vs Troponins in Chemotherapy-Induced Cardiotoxicity Detection (In Progress).
Impact of Hydrotherapy in Sports Medicine (In Progress).

Conclusion

Syed Aasim Syed Nasir embodies the qualities of a future physician-scientist: rigorous academic training, international exposure, leadership in medical organizations, and impactful research contributions across diverse medical domains. His growing portfolio of publications, presentations, and leadership roles underscores his ability to bridge clinical practice and academic medicine. With a strong commitment to innovation and patient-centered research, he is positioned to make significant contributions to medicine and global healthcare. His trajectory reflects not only individual excellence but also the potential to influence future medical research and practice on a global scale.

hassan noorbazargan | Immunology | Best Researcher Award

Published on 23/08/202523/08/2025 by Academic Excellence

Dr. hassan noorbazargan | Immunology | Best Researcher Award

Dr. hassan noorbazargan | Immunology | Carbon Technologies LLC | Oman

Dr. Hassan Noorbazargan is a highly accomplished researcher specializing in biotechnology, immunology, and molecular diagnostics. He earned his Ph.D. in Medical Biotechnology from Shahid Beheshti University of Medical Sciences, Iran, where his doctoral work focused on the design and validation of advanced PCR assays for detecting HIV. His career reflects a strong combination of academic excellence and industrial expertise, spanning molecular diagnostics, vaccine production, recombinant protein development, and nanobiotechnology. Dr. Noorbazargan has held prominent roles at Carbon Technologies Co., ROJE Technologies, and the Pasteur Institute of Iran, where he contributed significantly to diagnostic assay development and vaccine quality control. His research contributions have led to impactful publications on nanocarriers, drug delivery, and novel therapeutic strategies for infectious diseases and cancer. Dedicated to advancing biotechnology and immunology, Dr. Noorbazargan continues to shape the scientific community with his innovative work, quality leadership, and pursuit of translational research.

Author Profiles

Orcid | Google Scholar

Education

Dr. Hassan Noorbazargan pursued his Ph.D. in Biotechnology at Shahid Beheshti University of Medical Sciences, where he achieved a perfect GPA. His doctoral thesis focused on the design, development, and application of TaqMan real-time PCR for qualitative and quantitative detection of HIV, demonstrating his expertise in molecular diagnostics. Prior to this, he earned his M.Sc. in Microbiology from Islamic Azad University of Lahijan, where his thesis involved cloning and expression of the HCV core+1 protein in mammalian cells, highlighting his interest in virology and genetic engineering. He also completed his B.Sc. in Microbiology from the same university, where he developed a strong foundation in immunology, biochemistry, and cell biology. Through his academic journey, he undertook multiple research assistantships in microbiology and biotechnology labs, which helped refine his practical laboratory expertise. His educational achievements underline a consistent pursuit of excellence and research-driven learning.

Experience

Dr. Hassan Noorbazargan brings extensive experience in both academia and industry, specializing in diagnostics, vaccines, and nanobiotechnology. Currently serving as Senior Researcher & QC Head at Carbon Technologies Co., Muscat (2024–Present), he leads diagnostic kit validation for infectious diseases and ensures regulatory compliance. From 2019–2024, as Head of R&D at ROJE Technologies, he developed PCR assays for HIV, Hepatitis, and Influenza while managing technology transfer and GMP compliance. Earlier, he was a Senior R&D Specialist at Sinaclon, focusing on scaling molecular reagents and diagnostic kits. At the Pasteur Institute of Iran, he contributed as a Senior Scientist in BCG vaccine production and later as Scientific Advisor in vaccine development. His career also includes supervisory roles in clinical diagnostics and hands-on experience as a hospital lab technician. With a proven record in assay development, recombinant proteins, and nanocarriers, Dr. Noorbazargan continues to bridge research with translational healthcare solutions.

Awards and Honors

Throughout his career, Dr. Hassan Noorbazargan has earned recognition for his academic and research excellence in biotechnology and immunology. He successfully completed his Ph.D. with distinction at Shahid Beheshti University of Medical Sciences, where his groundbreaking work on HIV molecular detection positioned him as a leading scholar in molecular diagnostics. His innovative publications on nanocarriers, drug delivery systems, and novel therapeutic strategies for cancer and infectious diseases have been widely cited, reflecting their significant impact on the scientific community. He has also been acknowledged for his leadership in R&D roles, particularly in vaccine development and molecular assay validation, where his contributions directly influenced product innovation and clinical applications. In addition, Dr. Noorbazargan has participated in global training programs offered by WHO Academy, IAVI, Coursera, and edX, further strengthening his expertise. His ongoing pursuit of excellence and translational research has earned him recognition as a promising researcher in biotechnology and immunology.

Research Focus

Dr. Hassan Noorbazargan’s research is deeply rooted in immunology, nanobiotechnology, and molecular diagnostics. His focus lies in developing advanced diagnostic assays, nanocarrier-based drug delivery systems, and recombinant proteins for therapeutic and preventive medicine. A significant part of his work addresses infectious diseases such as HIV, Hepatitis, and COVID-19, where he has designed and validated cutting-edge PCR and ELISA-based assays for accurate detection. Beyond infectious diseases, his research explores innovative cancer therapies using niosomes, nanogels, and metal-organic frameworks for targeted and site-specific drug delivery. His publications highlight enhanced antibacterial, anticancer, and anti-metastatic strategies through engineered nanostructures, offering breakthroughs in precision medicine. He also contributes to vaccine research, optimizing immunogenicity assays and quality systems to improve vaccine safety and efficacy. By integrating molecular biology, immunology, and biotechnology, Dr. Noorbazargan’s research strengthens the bridge between laboratory innovation and clinical application, ultimately advancing global healthcare outcomes.

Publications

Narrative review on traditional medicine options for COVID-19 treatment.
Curcumin-loaded niosome nanocarriers for breast cancer therapy.
Ciprofloxacin-encapsulated niosomes for enhanced antibacterial activity.
Doxycycline-loaded niosomal formulation for prostate cancer treatment.
Niosome-loaded selenium nanoparticles for antibacterial and anticancer activities.
Folate-conjugated nanogels encapsulating oxaliplatin for colorectal cancer therapy.
Silver nanoparticles from Juniperus chinensis with anticancer properties.
Cefazolin-encapsulated UIO-66-NH2 nanoparticles against resistant S. aureus.
Folate-targeted curcumin-loaded niosomes for breast cancer treatment.
Biogenic AgNPs from Artemisia oliveriana for lung cancer therapy.
Engineered UIO-66 MOF delivering curcumin for breast cancer cells.
Super magnetic niosomal nanocarriers for breast cancer therapy.

Conclusion

Dr. Hassan Noorbazargan is a promising scientist whose research combines immunology, molecular diagnostics, and nanomedicine to address critical challenges in infectious diseases and cancer. With a balance of academic achievements, industrial expertise, and impactful publications, he stands as a strong candidate for global recognition in biomedical research.

Kiran Kharsodiya | Immunology | Women Researcher Award

Published on 23/08/202523/08/2025 by Academic Excellence

Dr. Kiran Kharsodiya | Immunology | Women Researcher Award

Dr. Kiran Kharsodiya | Immunology | Mody University of Science and Technology | India

Kiran Kharsodiya is a dedicated Research Scientist and Microbiologist with over eight years of experience in clinical, pharmaceutical, and microbiological research. Currently serving as Project Research Scientist II under the ICMR-CAR-MEDTECH Project at St. John’s Research Institute, Bengaluru, Kiran has made impactful contributions in designing and executing large-scale intervention and medical device trials. His expertise lies in microbiological examination, molecular analysis, and the study of host-inflammatory pathways. Kiran holds a strong research background supported by multiple peer-reviewed publications in international journals, reflecting his commitment to advancing medical science. His doctoral research at Mody University focuses on microbiological and molecular analysis of abnormal vaginal discharge and its pathophysiological effects, bridging microbiology and women’s health. A recipient of CSIR-NET qualification in 2024, Kiran exemplifies innovation, critical thinking, and leadership in translational research. His collaborative approach and scientific rigor continue to shape impactful research outcomes with real-world clinical applications.

Author Profiles

Orcid | Google Scholar

Education

Kiran Kharsodiya has pursued a strong academic foundation in microbiology and life sciences, which has shaped his career in biomedical research. He is currently completing his Doctor of Philosophy (PhD) at Mody University, India, where his thesis focuses on “Microbiological Examination and Molecular Analysis in Abnormal Vaginal Discharge and Comparative Analysis of its Pathophysiological Effect.” His PhD integrates molecular biology with clinical microbiology to explore diagnostic and therapeutic strategies in women’s health. Kiran earned his Master of Science (Microbiology) degree from Devi Ahilya University, Indore, India, where he specialized in advanced microbiological techniques and clinical research applications. He also completed a Bachelor of Science (Industrial Microbiology) from the same university, where his academic excellence and research curiosity laid the foundation for his career. Complementing his education, he successfully qualified the prestigious CSIR-NET exam in 2024, showcasing his academic excellence and research potential.

Experience

Currently working as Project Research Scientist II at St. John’s Research Institute, Bengaluru, under the ICMR-CAR-MEDTECH Project (2024–present), Kiran Kharsodiya brings extensive expertise in microbiology and clinical trial management. His role involves designing and executing large-scale pharmaceutical, medical device, and clinical trials, with a focus on ensuring regulatory compliance and high-quality data collection. He actively contributes to Phase III trials, large intervention efficiency studies, and the development of non-medical trial protocols. His ability to coordinate daily operations, collaborate with multidisciplinary teams, and analyze clinical trial data demonstrates his strong leadership in research environments. Kiran is also skilled in publishing and disseminating research findings through scientific journals and conferences, reinforcing his contributions to the broader scientific community. With more than eight years of research experience, he has developed a reputation for innovation, scientific precision, and problem-solving, contributing significantly to advancing biomedical and microbiological research in India and beyond.

Awards and Honors

Throughout his career, Kiran Kharsodiya has consistently demonstrated academic excellence and research dedication, earning several notable distinctions. His most recent achievement includes qualifying the prestigious CSIR-NET examination in 2024, a highly competitive recognition that reflects his advanced scientific knowledge and potential for research leadership. His contributions to translational microbiological and clinical research have also been acknowledged through multiple peer-reviewed publications, a testament to his innovation and dedication. Kiran has been invited to present his findings at national and international scientific conferences, highlighting the global relevance of his work. His collaborative research within multi-institutional projects, such as the ECGRI study on endometriosis and ovarian cancer, further underscores his recognition within the scientific community. These milestones, combined with his proven ability to integrate microbiology, molecular biology, and clinical research, establish him as a promising scientist whose work continues to be recognized for both academic rigor and societal impact.

Research Focus

Kiran Kharsodiya’s research focus lies at the intersection of microbiology, immunology, and women’s health. His PhD work emphasizes microbiological examination and molecular analysis of abnormal vaginal discharge, aiming to identify pathogenic flora, host-inflammatory responses, and their pathophysiological effects. This contributes to better diagnostic and therapeutic strategies for gynecological conditions. His studies also expand into the role of biomarkers, such as cytokines and microRNAs, in diseases like endometriosis and ovarian cancer, highlighting his interest in translational research. By integrating clinical microbiology, immunological pathways, and molecular diagnostics, Kiran seeks to improve early detection and intervention in reproductive health disorders. His work extends to exploring host-pathogen interactions, inflammation markers such as IL-6, IL-1β, TNF-α, and their predictive value in microbial infections. This research bridges fundamental microbiology with clinical applications, addressing pressing healthcare challenges. His long-term goal is to advance diagnostic tools and contribute meaningfully to global women’s healthcare solutions.

Publications

Protocol for a case–control study investigating the clinical phenotypes and genetic regulation of endometriosis in Indian women: the ECGRI study.
The relationship between melatonin 1-2 receptor expression in patients with epithelial ovarian cancer and survival.
Endometriosis in India: Analysing diagnostic delays, geographic variations, clinical phenotypes and associated characteristics from the ECGRI Study.
Predictive value of IL-6, IL-1β, TNF-α, and vaginal pH in diagnosing vaginal microbial infections: A host-inflammatory axis perspective.
Identification and characterization of pathogenic microbial flora associated with abnormal vaginal discharge: A microbiological examination study.
A pilot study of circulating microRNA-125b as a diagnostic & prognostic biomarker for epithelial ovarian cancer.
2022-RA-195-ESGO miRNA-125b expression in epithelial ovarian cancer.

Conclusion

Kiran Kharsodiya is a dynamic researcher with strong expertise in microbiology, immunology, and clinical research, making significant contributions to women’s health and translational medicine. His blend of academic rigor, practical experience in large-scale trials, and impactful publications positions him as a promising leader in biomedical sciences. With a clear focus on innovation, collaboration, and clinical relevance, he continues to advance knowledge at the crossroads of microbiology and immunology, striving to improve diagnostic and therapeutic outcomes for global healthcare.

Karthikeyan Kesavan | Pharmacology | Best Researcher Award

Published on 22/08/202522/08/2025 by Academic Excellence

Assoc. Prof. Dr. Karthikeyan Kesavan | Pharmacology | Best Researcher Award

Assoc. Prof. Dr. Karthikeyan Kesavan | Pharmacology | Department of Pharmacy, Guru Ghasidas University | India

Dr. Karthikeyan Kesavan is an accomplished academic and researcher serving as an Associate Professor in the Department of Pharmacy at Guru Ghasidas Vishwavidyalaya, Bilaspur. With a Ph.D. in Pharmaceutics from IIT-BHU and postdoctoral research experience at the University of Iowa under the DBT-GETin Fellowship, he has established himself as an expert in nanopharmaceuticals and ocular drug delivery. His research integrates nanotechnology with pharmaceutics to design innovative formulations for treating complex ocular and infectious diseases. Dr. Kesavan has guided Ph.D. and postgraduate scholars, published extensively in high-impact journals, authored influential book chapters, and holds multiple patents in novel drug delivery technologies. His consultancy projects also extend expertise in nanoformulations of natural metabolites for managing ocular diseases. With an H-index of 16 and growing international collaborations, Dr. Kesavan continues to bridge cutting-edge research with practical healthcare applications, contributing significantly to the advancement of pharmacology and pharmaceutical sciences.

Author Profiles

Orcid | Google Scholar

Education

Dr. Kesavan’s educational journey reflects excellence and dedication to pharmaceutical sciences. He earned his Bachelor of Pharmacy degree, which laid the foundation for his research interests, before pursuing a Master of Pharmacy (M. Pharm) in Pharmaceutics from Bharathidasan University. His academic passion led him to the prestigious Indian Institute of Technology (BHU), Varanasi, where he obtained his Ph.D. in Pharmaceutics, specializing in novel drug delivery systems. To further strengthen his expertise, he completed postdoctoral research at the University of Iowa, USA, under the distinguished DBT-GETin Fellowship, where he gained advanced experience in nanotechnology-based ocular drug delivery. This exposure enhanced his global outlook and scientific rigor, allowing him to integrate diverse approaches into his work. His education uniquely positioned him to contribute to both academic and industry-level pharmaceutical innovations. Today, his academic background continues to influence his impactful research in nanopharmaceuticals, ocular therapeutics, and gene delivery strategies.

Experience

Dr. Kesavan has more than a decade of experience in academia, research, and international collaboration. As an Associate Professor at Guru Ghasidas Vishwavidyalaya, he has played a pivotal role in advancing pharmaceutics education and research. His career includes mentoring doctoral and postgraduate students, designing advanced curricula, and fostering multidisciplinary projects. His consultancy experience extends to developing nanoformulations from medicinal plant metabolites for ocular disease management, bridging academia and applied science. Internationally, his postdoctoral research at the University of Iowa refined his expertise in nanocarrier-mediated gene therapy and non-viral delivery systems. Dr. Kesavan has completed projects funded by UGC, including innovative work on chitosan-coated cationic nanoemulsions for ocular delivery. His professional contributions encompass guiding clinical relevance, managing funded projects, publishing in SCI-indexed journals, authoring influential book chapters, and securing multiple patents. His diverse roles highlight his leadership in pharmacological innovation and his ability to translate research into practical applications.

Awards & Honors

Throughout his career, Dr. Kesavan has earned significant recognition for his contributions to pharmaceutics and drug delivery research. His selection for the prestigious DBT-GETin Fellowship enabled him to conduct postdoctoral research at the University of Iowa, expanding his international collaborations. He has been awarded UGC-BSR startup grants for innovative work in ocular nanopharmaceuticals, particularly chitosan-coated cationic nanoemulsions. His impactful research has led to multiple patent awards, including recognition for hybrid hydrogel systems and IoT-based health monitoring devices, demonstrating his interdisciplinary innovation. Beyond patents, his publications in high-impact journals and contributions to specialized book chapters highlight his scientific leadership. His role in guiding research scholars and his consultancy services further showcase his dedication to advancing pharmaceutical sciences. These honors not only validate his scientific excellence but also underscore his commitment to pioneering new frontiers in pharmacology and translating research into therapeutic solutions.

Research Focus

Dr. Kesavan’s research focus lies at the intersection of nanotechnology and pharmacology, with a special emphasis on ocular drug delivery systems. His investigations aim to overcome biological barriers by developing innovative nanocarriers, such as nanoemulsions, micelles, and nanocapsules, for improved treatment of eye diseases like glaucoma, uveitis, bacterial keratitis, and fungal infections. His work also explores gene therapy approaches using non-viral vectors for safer and more effective management of ocular disorders. In addition, his patents reflect his expertise in designing mucoadhesive, biocompatible systems that enhance therapeutic efficacy while reducing side effects. Expanding beyond ocular pharmacology, he has also contributed to cancer therapy and infectious disease research through nanocarrier-based formulations. By integrating pharmaceutical sciences with biotechnology and engineering, Dr. Kesavan’s research demonstrates translational value, bridging laboratory discoveries with clinical applications. His focus continues to advance the field of nanopharmaceuticals, ensuring patient-centered, innovative, and sustainable therapeutic solutions.

Publications

- Healing efficiency of nystatin-loaded chitosan-guar gum-based nanocapsules in experimental fungal keratitis.
- Tear-Driven Phase Transition Microemulsion for Ocular Delivery of Dexamethasone in Uveitis.
- Cationic microemulsion of voriconazole for fungal keratitis treatment: in vitro and in vivo evaluation.
- TPGS-Chitosan Conjugated Mucoadhesive Micelles of Brinzolamide for Glaucoma Therapy.
- Cationic Chitosan/Pectin Nanocapsules of Moxifloxacin for Bacterial Keratitis Management.
- Cationic Polyelectrolyte Nanocapsules of Moxifloxacin for Microbial Keratitis Therapy.
- Phase Transition Microemulsion of Brimonidine Tartrate for Glaucoma Therapy.
- Brinzolamide loaded chitosan-pectin mucoadhesive nanocapsules for glaucoma therapy.
- Positively Charged TPGS-Chitosan Nanocapsules as Non-Viral Vector for Glaucoma Gene Therapy.
- Topical Ocular Delivery of Nanocarriers: A Feasible Choice for Glaucoma Management.
- Ocular SMEDDS of Prednisolone for Improved Uveitis Therapy .
- Tamoxifen citrate loaded chitosan-gellan nanocapsules for breast cancer therapy.
- Phase Transition W/O Microemulsions for Antibacterial Activity in Bacterial Keratitis.
- Chitosan-Coated Microemulsions for Enhanced Dermal Clotrimazole Delivery.

Conclusion

Dr. Karthikeyan Kesavan exemplifies excellence in pharmacology through his pioneering research in nanopharmaceuticals, ocular drug delivery, and innovative therapeutic approaches. With a strong educational foundation, impactful teaching experience, and international collaborations, he has established himself as a leader in pharmaceutical research. His extensive publications, patents, and consultancy work highlight his contributions to both academic and industrial advancements. Dr. Kesavan’s dedication to addressing unmet medical needs through nanotechnology-driven solutions continues to shape the future of pharmacology, making him a highly deserving candidate for recognition in the field.